Company Name: Idoven
Location: Madrid, Spain
Nature of Business: AI cardiology-as-a-service platform
Funding: Undisclosed amount
- Northzone and Insight Partners
- Gasol16 Ventures (led by NBA player Pau Gasol)
- Hambro Perks
- Adam Chekroud (Spring Health co-founder)
- Luis Sanz (Carto CEO)
As a former elite athlete, I know firsthand how important early detection and prevention can be to maintaining optimal health, especially when it comes to cardiovascular issues. I am thrilled to contribute with my expertise and knowledge, building a strong and successful team culture in a company which has the potential to save thousands of lives, as well as my network and reach to help Idoven scale at such a crucial phase of its growth. Idoven’s AI technology is completely changing how we measure a healthy heart and prevent and treat heart related disease, something I think will make a big difference. - Pau Gasol
Purpose for Funds: Deploy new solutions, improve diagnosis capabilities for cardiovascular diseases, and expand globally.
Product/Service: Idoven has developed an AI cardiology-as-a-service platform to help cardiologists and clinicians identify, triage, and diagnose patients. Originally a desktop software in 2018, it transitioned into a cloud-based AI tool adopted by medical device manufacturers and pharmaceutical companies. Idoven now integrates with third-party tools, software, and digital solutions.
Company Leadership: Led by cardiologist and CEO, Manuel Marina Breysse.
Partnerships: AstraZeneca, Abbott, GE Healthcare, FIFPRO, Google, Santander, and the Real Madrid Foundation.